Immune Mediated Disease/Transplantation

Ruzek MC, Waire JS, Hopkins D, Lacorcia G, Sullivan J, Roberts BL, Richards SM, Nahill SR, Williams JM, Scaria A, Dzuris J, Shankara S, Garman RD. 2008. Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivo. Blood 111:1726-1734.

Tedstone JL, Richards SM, Garman RD, Ruzek MC. 2008. Ultrasound imaging accurately detects skin thickening in a mouse scleroderma model. Ultrasound in Med & Biol 34(8):1239-47.

Chung DT, Korn T, Richard J, Ruzek M, Kohm AP, Miller S, Nahill S, Oukka M. 2007. Anti-thymocyte globulin (ATG) prevents autoimmune encephalomyelitis by expanding myelin antigen-specific Foxp3+ regulatory T cells. Intl Immunology 19(8):1003-10.

Ruzek M, Dzuris J, Gao L, Bigelow R, Waire J, Scaria A, Nahill S, Williams J. 2007. Selected mechanistic studies and future directions for thymoglobulin. Transplantation 84(11 S SUPPL):S27-S34.

Woodside KJ, Hu M, Liu Y, Song W, Hunter GC, Daller JA. 2006. Apoptosis of allospecifically activated human helper T cells is blocked by calcineurin inhibition. Transplant Immunol 15:229-234

Dreier L, Burbea M, Kaplan JM. 2005. LIN-23-mediated degradation of beta-catenin regulates the abundance of GLR-1 glutamate receptors in the ventral nerve cord of C. elegans. Neuron 46:51-64.

DeVry CG, Valdez M, Gao L, Wang J, Kotsch K, Volk HD, Bechmann I, Buelow R, Iyer S. 2004. RDP58, a novel immunomodulatory peptide, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalomyelitis. J Neuroimmunol 152:33-43.

Dodge J, C., Badura LL. 2004. Noradrenergic regulation of prolactin secretion at the level of the paraventricular nucleus of the hypothalamus: functional significance of the alpha-1b and beta-adrenergic receptor subtypes. Brain Res 1016:240-246.

Magner JA. 2004. Thyroid-stimulating hormone-mediated hyperthyroidism. Endocrinologist 14:201-211.

Petri MA, Mease PJ, Merrill JT, Lahita RG, Iannini MJ, Yocum DE, Ginzler EM, Katz RS, Gluck OS, Genovese MC, Van Vollenhoven R, Kalunian KC, Manzi S, Greenwald MW, Buyon JP, Olsen NJ, Schiff MH, Kavanaugh AF, Caldwell JR, Ramsey-Goldman R, St Clair EW, Goldman AL, Egan RM, Polisson RP, Moder KG, Rothfield NF, Spencer RT, Hobbs K, Fessler BJ, Calabrese LH, Moreland LW, Cohen SB, Quarles BJ, Strand V, Gurwith M, Schwartz KE. 2004. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus. Arthritis Rheum 50:2858-2868.

Ruzek MC, Jha S, Ledbetter S, Richards SM, Garman RD. 2004. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease. Arthritis Rheum 50:1319-1331.

Ruzek MC, Hawes M, Pratt B, McPherson J, Ledbetter S, Richards SM, Garman RD. 2003. Minimal effects on immune parameters following chronic anti-TGF-beta monoclonal antibody administration to normal mice. Immunopharmacol Immunotoxicol 25:235-257.

Sun R, Gault RA, Welniak LA, Tian ZG, Richards S, Murphy WJ. 2003. Immunologic and hematopoietic effects of recombinant human prolactin after syngeneic bone marrow transplantation in mice. Biol Blood Marrow Transplant 9:426-434.

Richards SM. 2002. Human prolactin as an immunohematopoietic factor: implications for the clinic. In: Rapaport R, Matera L, editors. Neuroimmune Biology: Elsevier Science. p 275-286.